Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states (Q34406761)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states |
scientific article |
Statements
1 reference
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states (English)
1 reference
T Yoshida
1 reference
Y Ozawa
1 reference
T Kimura
1 reference
Y Sato
1 reference
G Kuznetsov
1 reference
S Xu
1 reference
M Uesugi
1 reference
S Agoulnik
1 reference
N Taylor
1 reference
Y Funahashi
1 reference
J Matsui
1 reference
25 February 2014
1 reference
1 reference
110
1 reference
6
1 reference
1497-1505
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference